Notably, most of the relevant actors involved in the anti-tumour immune response have been described to express DRD3, including CD8+ T-cells, effector CD4+ T-cells, Treg, macrophages, NK cells, B-cells, and DCs [10,13,23,24,25]. Here, CD4 is linked to neoplasm.